PL2470907T3 - Białko stosowane w diagnostyce boreliozy z Lyme - Google Patents

Białko stosowane w diagnostyce boreliozy z Lyme

Info

Publication number
PL2470907T3
PL2470907T3 PL10763756T PL10763756T PL2470907T3 PL 2470907 T3 PL2470907 T3 PL 2470907T3 PL 10763756 T PL10763756 T PL 10763756T PL 10763756 T PL10763756 T PL 10763756T PL 2470907 T3 PL2470907 T3 PL 2470907T3
Authority
PL
Poland
Prior art keywords
diagnosis
proteins used
lyme borreliosis
borreliosis
lyme
Prior art date
Application number
PL10763756T
Other languages
English (en)
Inventor
Lionel Levet
Odile Mejan-Letourneur
Original Assignee
Biomerieux Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux Sa filed Critical Biomerieux Sa
Publication of PL2470907T3 publication Critical patent/PL2470907T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4233—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-bacterial Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/20—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
PL10763756T 2009-08-28 2010-08-26 Białko stosowane w diagnostyce boreliozy z Lyme PL2470907T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0904093A FR2949472B1 (fr) 2009-08-28 2009-08-28 Proteines utilisees pour le diagnostic d'une borreliose de lyme
EP10763756.3A EP2470907B1 (fr) 2009-08-28 2010-08-26 Proteines utilisees pour le diagnostic d'une borreliose de lyme
PCT/FR2010/051780 WO2011023909A1 (fr) 2009-08-28 2010-08-26 Proteines utilisees pour le diagnostic d'une borreliose de lyme

Publications (1)

Publication Number Publication Date
PL2470907T3 true PL2470907T3 (pl) 2015-01-30

Family

ID=42046350

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10763756T PL2470907T3 (pl) 2009-08-28 2010-08-26 Białko stosowane w diagnostyce boreliozy z Lyme

Country Status (7)

Country Link
US (3) US9347943B2 (pl)
EP (1) EP2470907B1 (pl)
ES (1) ES2500651T3 (pl)
FR (1) FR2949472B1 (pl)
PL (1) PL2470907T3 (pl)
RU (1) RU2549698C2 (pl)
WO (1) WO2011023909A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2949472B1 (fr) * 2009-08-28 2013-08-09 Biomerieux Sa Proteines utilisees pour le diagnostic d'une borreliose de lyme
WO2015054319A1 (en) * 2013-10-07 2015-04-16 University Of Central Florida Research Foundation, Inc. Method, kits and materials for detection of lyme disease borrelia sp. infection
WO2018017998A1 (en) * 2016-07-22 2018-01-25 The Research Foundation For The State University Of New York Recombinant borrelia proteins and methods of use thereof
RU2681229C1 (ru) * 2017-11-03 2019-03-05 Федеральное бюджетное учреждение науки Государственный научный центр прикладной микробиологии и биотехнологии (ФБУН ГНЦ ПМБ) Нуклеотидная последовательность, кодирующая полипептид DBPAG, перспективный для серодиагностики клещевого боррелиоза, рекомбинантная плазмидная ДНК pETdbpagNH, кодирующая слитный полипептид DBPAG, рекомбинантный штамм бактерий Escherichia coli BL21(DE3)/ pETdbpagNH - продуцент полипептида DBPAG, полипептид DBPAG и способ его получения
WO2020264341A1 (en) * 2019-06-26 2020-12-30 The Johns Hopkins University Compositions and methods for lyme disease

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2102081C1 (ru) * 1991-07-11 1998-01-20 Иммуно АГ Иммуногенная композиция против боррелиоза лайма, способ иммунизации млекопитающего против боррелиоза лайма, способ получения белка pc borrelia burgdorferi, диагностический агент для обнаружения b.burgdorferi и способ обнаружения антител к b.burgdorferi
US5620862A (en) * 1993-11-24 1997-04-15 University Of Connecticut Methods for diagnosing early Lyme disease
DE19632862B4 (de) * 1996-08-14 2006-08-03 Mikrogen Molekularbiologische Entwicklungs-Gmbh Immunologisch aktive Proteine von Borrelia burgdorferi, dafür kodierende Nukleinsäuren sowie deren Verwendung in Testkits und als Impfstoffe
US6475492B1 (en) 1999-04-28 2002-11-05 The Administrators Of The Tulane Educational Fund Peptides and assays for the diagnosis of lyme disease
ATE340262T1 (de) * 1999-06-18 2006-10-15 Univ New York State Res Found Gruppen von borrelia burgdorferi, die lyme krankheit verursachen
AU5622800A (en) * 1999-06-18 2001-01-09 Med Immune, Inc. Combined decorin binding protein and outer surface protein compositions and methods of use
RU2260047C2 (ru) * 2003-10-23 2005-09-10 Государственное учреждение Научно-исследовательский институт биохимии Сибирского отделения Российской академии медицинских наук Рекомбинантная плазмидная днк, обеспечивающая синтез иммунодоминантного белка borrelia garinii, используемого для диагностики лайм-боррелиоза (варианты)
WO2007133623A2 (en) * 2006-05-10 2007-11-22 Biopeptides Corporation Peptide diagnostic agent for lyme disease
FR2949472B1 (fr) * 2009-08-28 2013-08-09 Biomerieux Sa Proteines utilisees pour le diagnostic d'une borreliose de lyme

Also Published As

Publication number Publication date
US9347943B2 (en) 2016-05-24
RU2012111811A (ru) 2013-10-10
WO2011023909A1 (fr) 2011-03-03
EP2470907A1 (fr) 2012-07-04
US20170205407A1 (en) 2017-07-20
ES2500651T3 (es) 2014-09-30
FR2949472B1 (fr) 2013-08-09
US20180238874A1 (en) 2018-08-23
EP2470907B1 (fr) 2014-06-25
US9977020B2 (en) 2018-05-22
RU2549698C2 (ru) 2015-04-27
FR2949472A1 (fr) 2011-03-04
US20120135027A1 (en) 2012-05-31

Similar Documents

Publication Publication Date Title
EP2649944A4 (en) Ultrasound diagnosis apparatus
EP2659826A4 (en) Endoscopic diagnosis apparatus
GB2479176B (en) Surgical instrument
EP2691036A4 (en) SURGICAL ULTRASOUND INSTRUMENTS
EP2614776A4 (en) Ultrasound diagnostic equipment
IT1398238B1 (it) Strumento per la chirurgia robotica
EP2550909A4 (en) ENDOSCOPE DEVICE
ZA201304196B (en) Diagnostic system
EP2520211A4 (en) FLUORESCENCE ENDOSCOPE DEVICE
EP2474273A4 (en) PLIERS FOR ENDOSCOPES
EP2520212A4 (en) FLUORESCENCE ENDOSCOPE DEVICE
GB201008541D0 (en) Diagnostic methods
ZA201302402B (en) Methods for diagnosing lyme disease
GB2498491B (en) Diagnostic system
IL213917A0 (en) Novel compounds for medical use as peptidase effectors
EP2691034A4 (en) ULTRASONIC SURGICAL INSTRUMENTS
IL231982B (en) A method for the diagnosis of Niemann-Pick disease
GB201011420D0 (en) Method for diagnosis
GB201016161D0 (en) Diagnostic method
GB201008719D0 (en) Diagnostic method
EP2420189A4 (en) ULTRASOUND DIAGNOSTIC DEVICE
PL2470907T3 (pl) Białko stosowane w diagnostyce boreliozy z Lyme
EP2549917A4 (en) DIAGNOSTIC DEVICE FOR DETERMINING THE MECHANICAL INTEGRITY OF BONE
ZA201301498B (en) Diagnostic method
PL2693216T3 (pl) Sposób diagnozowania lub wstępnego diagnozowania beta-amyloidopatii